edaravone

E133688

Edaravone is a neuroprotective drug used to slow functional decline in patients with amyotrophic lateral sclerosis (ALS).

All labels observed (1)

Label Occurrences
edaravone canonical 1

How this entity was disambiguated

Statements (48)

Predicate Object
instanceOf antioxidant
free radical scavenger
neuroprotective agent
pharmaceutical drug
small molecule
approvedBy Food and Drug Administration
surface form: FDA

Food and Drug Administration
surface form: U.S. Food and Drug Administration
belongsToDrugClass free radical scavengers
neuroprotective drugs
developedFor treatment of amyotrophic lateral sclerosis
eliminatedBy kidney
FDAApprovalYear 2017
firstApprovedForALS Japan
firstApprovedForIndication acute ischemic stroke in Japan
hasATCCode N07XX11
hasBlackBoxWarning risk of hypersensitivity reactions including anaphylaxis (U.S.)
hasBrandName Radicava
Radicava ORS
Radicut
hasCASNumber 89-25-8
hasChemicalFormula C10H10N2O
hasCommonAdverseEffect contusion
eczema
gait disturbance
headache
respiratory failure
hasEliminationHalfLife approximately 4.5 to 6 hours (intravenous)
hasIUPACName 3-methyl-1-phenyl-2-pyrazolin-5-one
hasLegalStatus prescription-only medicine
hasMechanismOfAction reduces oxidative stress
scavenges free radicals
hasMolarMass 174.20 g/mol
hasPharmacologicalAction neuroprotection in motor neurons
hasPregnancyCategory not well established in humans
hasRouteOfAdministration intravenous
oral
hasSeriousAdverseEffect anaphylaxis
hypersensitivity reactions
hasTargetPopulation adult patients with ALS
hasTherapeuticEffect slows functional decline in ALS patients
indication treatment of ALS in adults
isAdministeredOnSchedule cyclic dosing regimen for ALS
isContraindicatedIn patients with history of hypersensitivity to edaravone
patients with sulfite hypersensitivity (for some formulations)
metabolizedBy liver
treats ALS
amyotrophic lateral sclerosis
wasFirstApprovedIn Japan

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

ALS hasTreatment edaravone